Cardiovascular Safety of Prokinetic Agents: A Focus on Drug-induced Arrhythmias

Overview

Journal Neurogastroenterol Motil

Specialties Gastroenterology
Neurology

Date 2018 Feb 15

PMID 29441683

Citations 28

Authors

J R Giudicessi

M J Ackerman

M Camilleri

Affiliations

Soon will be listed here.

Abstract

Background: Gastrointestinal sensorimotor dysfunction underlies a wide range of esophageal, gastric, and intestinal motility and functional disorders that collectively constitute nearly half of all referrals to gastroenterologists. As a result, substantial effort has been dedicated toward the development of prokinetic agents intended to augment or restore normal gastrointestinal motility. However, the use of several clinically efficacious gastroprokinetic agents, such as cisapride, domperidone, erythromycin, and tegaserod, is associated with unfavorable cardiovascular safety profiles, leading to restrictions in their use.

Purpose: The purpose of this review is to detail the cellular and molecular mechanisms that lead commonly to drug-induced cardiac arrhythmias, specifically drug-induced long QT syndrome, torsades de pointes, and ventricular fibrillation, to examine the cardiovascular safety profiles of several classes of prokinetic agents currently in clinical use, and to explore potential strategies by which the risk of drug-induced cardiac arrhythmia associated with prokinetic agents and other QT interval prolonging medications can be mitigated successfully.

Citing Articles

White Tea Reduces Dyslipidemia, Inflammation, and Oxidative Stress in the Aortic Arch in a Model of Atherosclerosis Induced by Atherogenic Diet in ApoE Knockout Mice.

Huner Yigit M, Atak M, Yigit E, Suzan Z, Kivrak M, Uydu H Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770544 PMC: 11679696. DOI: 10.3390/ph17121699.

Advances in the Preparation, Stability, Metabolism, and Physiological Roles of Anthocyanins: A Review.

Li Q, Zhang F, Wang Z, Feng Y, Han Y Foods. 2023; 12(21).

PMID: 37959087 PMC: 10647620. DOI: 10.3390/foods12213969.

Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson's disease.

Grigoletto J, Miraglia F, Benvenuti L, Pellegrini C, Soldi S, Galletti S NPJ Parkinsons Dis. 2023; 9(1):140.

PMID: 37783672 PMC: 10545757. DOI: 10.1038/s41531-023-00582-1.

Baclofen as a therapeutic option for gastroesophageal reflux disease: A systematic review of clinical trials.

Arabpour E, Khoshdel S, Akhgarzad A, Abdi M, Tabatabaie N, Alijanzadeh D Front Med (Lausanne). 2023; 10:997440.

PMID: 36873860 PMC: 9981648. DOI: 10.3389/fmed.2023.997440.

Pharmacokinetic Optimization of Small Molecule Janus Kinase 3 Inhibitors to Target Immune Cells.

Laux J, Forster M, Riexinger L, Schwamborn A, Guezguez J, Pokoj C ACS Pharmacol Transl Sci. 2022; 5(8):573-602.

PMID: 35983274 PMC: 9380220. DOI: 10.1021/acsptsci.2c00054.

References

Tisdale J, Jaynes H, Kingery J, Mourad N, Trujillo T, Overholser B . Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013; 6(4):479-87. PMC: 3788679. DOI: 10.1161/CIRCOUTCOMES.113.000152. View

Snyders D, Chaudhary A . High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol. 1996; 49(6):949-55. View

Gross A, Goh Y, Addison R, Shenfield G . Influence of grapefruit juice on cisapride pharmacokinetics. Clin Pharmacol Ther. 1999; 65(4):395-401. DOI: 10.1016/S0009-9236(99)70133-5. View

Olsson S, Edwards I . Tachycardia during cisapride treatment. BMJ. 1992; 305(6856):748-9. PMC: 1883438. DOI: 10.1136/bmj.305.6856.748-a. View

Eckhardt L, Rajamani S, January C . Protein trafficking abnormalities: a new mechanism in drug-induced long QT syndrome. Br J Pharmacol. 2005; 145(1):3-4. PMC: 1576114. DOI: 10.1038/sj.bjp.0706143. View

van Noord C, Dieleman J, van Herpen G, Verhamme K, Sturkenboom M . Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf. 2010; 33(11):1003-14. DOI: 10.2165/11536840-000000000-00000. View

Leclere P, Prins N, Schuurkes J, Lefebvre R . 5-HT4 receptors located on cholinergic nerves in human colon circular muscle. Neurogastroenterol Motil. 2005; 17(3):366-75. DOI: 10.1111/j.1365-2982.2005.00621.x. View

Rao A, Camilleri M . Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2009; 31(1):11-9. DOI: 10.1111/j.1365-2036.2009.04189.x. View

Sifrim D, Matsuo H, Janssens J, VANTRAPPEN G . Comparison of the effects of midecamycin acetate and azithromycin on gastrointestinal motility in man. Drugs Exp Clin Res. 1994; 20(3):121-6. View

10.

Frommeyer G, Eckardt L . Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms. Nat Rev Cardiol. 2015; 13(1):36-47. DOI: 10.1038/nrcardio.2015.110. View

11.

JACOBY H, Brodie D . Gastrointestinal actions of metoclopramide. An experimental study. Gastroenterology. 1967; 52(4):676-84. View

12.

Ray W, Murray K, Hall K, Arbogast P, Stein C . Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012; 366(20):1881-90. PMC: 3374857. DOI: 10.1056/NEJMoa1003833. View

13.

Kuryshev Y, Brown A, Wang L, Benedict C, Rampe D . Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther. 2000; 295(2):614-20. View

14.

Camilleri M, Parkman H, Shafi M, Abell T, Gerson L . Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2012; 108(1):18-37. PMC: 3722580. DOI: 10.1038/ajg.2012.373. View

15.

Witchel H, Pabbathi V, Hofmann G, Paul A, Hancox J . Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents. FEBS Lett. 2002; 512(1-3):59-66. DOI: 10.1016/s0014-5793(01)03320-8. View

16.

Suessbrich H, Schonherr R, Heinemann S, Attali B, Lang F, Busch A . The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br J Pharmacol. 1997; 120(5):968-74. PMC: 1564549. DOI: 10.1038/sj.bjp.0700989. View

17.

Wager E, Tooley P, Pearce G, Wilton L, Mann R . A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV study. Eur J Clin Pharmacol. 1997; 52(2):87-94. DOI: 10.1007/s002280050255. View

18.

SELZER A, WRAY H . QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS. Circulation. 1964; 30:17-26. DOI: 10.1161/01.cir.30.1.17. View

19.

Jones J, Fife D, Curkendall S, Goehring Jr E, Guo J, Shannon M . Coprescribing and codispensing of cisapride and contraindicated drugs. JAMA. 2001; 286(13):1607-9. DOI: 10.1001/jama.286.13.1607. View

20.

Kang J, Wang L, Chen X, Triggle D, Rampe D . Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. Mol Pharmacol. 2000; 59(1):122-6. DOI: 10.1124/mol.59.1.122. View